department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Enliven Therapeutics, Inc. ($ELVN) · pharmadog

PUBLIC COMPANY

$ELVNEnliven Therapeutics, Inc.

Boulder, CO, USupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

2

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Phase 11Phase 2

Human Epidermal Growth Factor Receptor 2 Positive Breast…

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Enliven Therapeutics, Inc. jobs →

News

no news has mentioned this company yet

identifiers

ticker

$ELVN

SEC CIK

0001672619

country

US

source

sec_tickers

top tags

Oncology2 Colorectal Cancer1

mentioned in

0news items

entity-linker matched

$ELVN

Data sources

last refreshed 32m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

phase1A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemiarecruitingn=250
phase1ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Canceractive not recruitingn=275
phase1ELVN-002 in HER2 Mutant Non-Small Cell Lung Canceractive not recruitingn=198
phase1ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participantsrecruitingn=21

Insider activity

source: SEC Form 4

90d open-market buys

$0

0 transactions

90d open-market sells

$238K

3 transactions

net (buys − sells)

−$238K

non-derivative only

open-market buys + sells

Apr 17, 26SELLCollins Helen Louise· CHIEF MEDICAL OFFICER2,441 sh @ $48.06−$117K↗
Apr 17, 26SELLCollins Helen Louise· CHIEF MEDICAL OFFICER2,419 sh @ $47.39−$115K↗
Apr 17, 26SELLCollins Helen Louise· CHIEF MEDICAL OFFICER140 sh @ $45.81−$6K↗
Mar 25, 26SELLCollins Helen Louise· CHIEF MEDICAL OFFICER40,000 sh @ $35.10−$1.40M↗
Mar 17, 26SELLCollins Helen Louise· CHIEF MEDICAL OFFICER5,000 sh @ $27.76−$139K↗
Mar 10, 26SELLCollins Helen Louise· CHIEF MEDICAL OFFICER10,129 sh @ $30.19−$306K↗
Mar 9, 26SELLCollins Helen Louise· CHIEF MEDICAL OFFICER29,871 sh @ $30.02−$897K↗
Mar 6, 26SELLHohl Benjamin· CHIEF FINANCIAL OFFICER10,000 sh @ $29.58−$296K↗
Feb 17, 26SELLCollins Helen Louise· CHIEF MEDICAL OFFICER45,000 sh @ $26.17−$1.18M↗
Feb 17, 26SELLHeyman Richard A.· 1,230 sh @ $26.18−$32K↗
Feb 6, 26SELLLyssikatos Joseph P· CHIEF SCIENTIFIC OFFICER5,000 sh @ $29.04−$145K↗

routine RSU / option mechanics (6)

Apr 17, 26option exerciseCollins Helen Louise · CHIEF MEDICAL OFFICER5,000 sh
Apr 17, 26option exerciseCollins Helen Louise · CHIEF MEDICAL OFFICER5,000 sh
Mar 25, 26option exerciseCollins Helen Louise · CHIEF MEDICAL OFFICER40,000 sh
Mar 25, 26option exerciseCollins Helen Louise · CHIEF MEDICAL OFFICER40,000 sh
Mar 17, 26option exerciseCollins Helen Louise · CHIEF MEDICAL OFFICER5,000 sh

Mar 17, 26

option exercise

Collins Helen Louise · CHIEF MEDICAL OFFICER

5,000 sh